Mymetics Financial Statements From 2010 to 2024

MYMX Stock  USD 0  0.00  0.00%   
Mymetics Corp financial statements provide useful quarterly and yearly information to potential Mymetics Corp investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Mymetics Corp financial statements helps investors assess Mymetics Corp's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Mymetics Corp's valuation are summarized below:
Mymetics Corp does not presently have any fundamental ratios for analysis.
Check Mymetics Corp financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Mymetics Corp's main balance sheet or income statement drivers, such as , as well as many indicators such as . Mymetics financial statements analysis is a perfect complement when working with Mymetics Corp Valuation or Volatility modules.
  
This module can also supplement various Mymetics Corp Technical models . Check out the analysis of Mymetics Corp Correlation against competitors.

Mymetics Corp Company Operating Margin Analysis

Mymetics Corp's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.

Operating Margin

 = 

Operating Income

Revenue

X

100

More About Operating Margin | All Equity Analysis

Current Mymetics Corp Operating Margin

    
  (1.76) %  
Most of Mymetics Corp's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Mymetics Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
Competition

Based on the recorded statements, Mymetics Corp has an Operating Margin of -1.7611%. This is 94.98% lower than that of the Biotechnology sector and 98.43% lower than that of the Health Care industry. The operating margin for all United States stocks is 68.04% lower than that of the firm.

Mymetics Corp Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Mymetics Corp's current stock value. Our valuation model uses many indicators to compare Mymetics Corp value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Mymetics Corp competition to find correlations between indicators driving Mymetics Corp's intrinsic value. More Info.
Mymetics Corp is regarded second in return on asset category among its peers. It is considered to be number one stock in operating margin category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Mymetics Corp by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Mymetics Corp's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

About Mymetics Corp Financial Statements

Mymetics Corp investors use historical fundamental indicators, such as Mymetics Corp's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Mymetics Corp. Please read more on our technical analysis and fundamental analysis pages.
Mymetics Corporation, a vaccine company, engages in the research and development of vaccines for infectious and life disabling diseases in Switzerland. Mymetics Corporation was founded in 1990 and is based in Epalinges, Switzerland. Mymetics Corp operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 8 people.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Mymetics Pink Sheet Analysis

When running Mymetics Corp's price analysis, check to measure Mymetics Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mymetics Corp is operating at the current time. Most of Mymetics Corp's value examination focuses on studying past and present price action to predict the probability of Mymetics Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mymetics Corp's price. Additionally, you may evaluate how the addition of Mymetics Corp to your portfolios can decrease your overall portfolio volatility.